Risk of major hemorrhage for outpatients treated with warfarin

被引：0

作者：

Deborah A. McMahan

David M. Smith

Mark A. Carey

Xiao Hua Zhou

机构：

[1] the Richard L. Roudebush VAMC,the Division of Biostatistics, Department of Medicine

[2] the Division of General Internal Medicine,undefined

[3] Indiana University School of Medicine,undefined

[4] the Regenstrief Institute for Health Care,undefined

[5] Medical Group of Fort Wayne,undefined

来源：

Journal of General Internal Medicine | 1998年 / 13卷

关键词：

major hemorrhage; warfarin; alcohol abuse; chronic renal insufficiency; gastrointestinal hemorrhage;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

OBJECTIVE: To determine the incidence of major hemorrhage among outpatients started on warfarin therapy after the recommendation in 1986 for reduced-intensity anticoagulation therapy was made, and to identify baseline patient characteristics that predict those patients who will have a major hemorrhage.

引用

页码：311 / 316

页数：5

共 50 条

[31] Influence of Age on Warfarin Dose, Anticoagulation Control, and Risk of Hemorrhage
Shendre, Aditi
Parmar, Gaurav M.
Dillon, Chrisly
Beasley, Timothy Mark
Limdi, Nita A.
PHARMACOTHERAPY, 2018, 38 (06): : 588 - 596
[32] Incidence of and Risk Factors for Major Hemorrhage in Patients Treated with Ibrutinib: Results from an Integrated Analysis
Brown, Jennifer R.
Moslehi, Javid
Ewer, Michael S.
O'Brien, Susan M.
Ghia, Paolo
Cymbalista, Florence
Shanafelt, Tait D.
Fraser, Graeme
Rule, Simon
Coutre, Steven E.
Dilhuydy, Marie-Sarah
Cramer, Paula
Jaeger, Ulrich
Dreyling, Martin
Byrd, John C.
Treon, Steven
Liu, Emily
Chang, Stephen
Bista, Amulya
Vempati, Rama
Boornazian, Lisa
Valentino, Rudolph
Reddy, Vijay
Mahler, Michelle
Yang, Huiying
Burger, Jan A.
BLOOD, 2017, 130
[33] Major bleeding risk with warfarin for deep vein thrombosis
Linkins, LA
Choi, PT
Douketis, JD
CLEVELAND CLINIC JOURNAL OF MEDICINE, 2004, 71 (04) : 282 - 282
[34] Genotype and risk of major bleeding during warfarin treatment
Kawai, Vivian K.
Cunningham, Andrew
Vear, Susan I.
Van Driest, Sara L.
Oginni, Abimbola
Xu, Hua
Jiang, Min
Li, Chun
Denny, Joshua C.
Shaffer, Christian
Bowton, Erica
Gage, Brian F.
Ray, Wayne A.
Roden, Dan M.
Stein, C. Michael
PHARMACOGENOMICS, 2014, 15 (16) : 1973 - 1983
[35] Predictive ability of scores for bleeding risk in heart disease outpatients on warfarin in Brazil
de Queiroz Oliveira, Joao Antonio
Pinho Ribeiro, Antonio Luiz
Ribeiro, Daniel Dias
Nobre, Vandack
da Costa Rocha, Manoel Otavio
Parreiras Martins, Maria Auxiliadora
PLOS ONE, 2018, 13 (10):
[36] Brief report: The risk of overanticoagulation with antibiotic use in outpatients on stable warfarin regimens
Jeffrey J. Glasheen
Randolph V. Fugit
Allan V. Prochazka
Journal of General Internal Medicine, 2005, 20 : 653 - 656
[37] Genetic Predisposition Influences Anticoagulation Control and Major Hemorrhage Among Warfarin Users
Shendre, Aditi
Brown, Todd M.
Liu, Nianjun
Beasley, T. M.
Hill, Charles E.
Limdi, Nita A.
CIRCULATION, 2015, 132
[38] The Risk of Major Bleeding in Patients Treated with Warfarin for Venous Thromboembolism at an Anticoagulation Clinic: An Incident User Cohort Study
Johnson, Eric S.
Smith, David H.
Yang, Xiuhai
Petrik, Amanda F.
Weiss, Jessica R.
Thorp, Micah L.
Felcher, Andrew H.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S146 - S146
[39] Risk of bacteremia in young children with pneumonia treated as outpatients
Shah, SS
Alpern, ER
Zwerling, L
McGowan, RL
Bell, LM
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2003, 157 (04): : 389 - 392
[40] Acute Massive Suprachoroidal Hemorrhage after Photodynamic Therapy in a Patient Treated with Warfarin
Petropoulos, I. K.
Ekonomidis, P.
Theoulakis, P. E.
Gatzogias, M. I.
Katsimpris, J. M.
KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2009, 226 (04) : 365 - 367

← 1 2 3 4 5 →